By Gwenaëlle Douaud, et al. With comment from Dr. Bob Rufsvold The research from the UK is a worrisome tip-of-the-iceberg indicator, one that goes beyond our current understanding of “Long COVID” symptoms that many people are experiencing.Bob Rufsvold MD Abstract...
COVID Calculator: Predict YOUR Chance of Hospitalization or Death
Researchers in Israel developed a COVID calculator to predict anyone’s chance of getting hospitalized with COVID-19 or dying from it once infected. Dr. Ariel Israel MD, Ph.D., et. al. created the calculator, the basis for which is published as a preprint...
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
By Venice Servellita, et al. PREPrint ~ August 25, 2021 with Commentary from TrialSiteNews Below Abstract Associations between vaccine breakthrough cases and infection by SARS coronavirus 2 (SARS-CoV-2) variants have remained largely unexplored. Here we analyzed...
Common dandelion (Taraxacum officinale) efficiently blocks the interaction between ACE2 cell surface receptor and SARS-CoV-2 spike protein D614, mutants D614G, N501Y, K417N and E484K in vitro
By Hoai Thi Thu Tran ~ PREPrint article ~ March 19, 2021 ~ & Review below Abstract On 11th March 2020, coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, was declared as a global pandemic by the World Health Organization (WHO). To date, there are...
The SARS-CoV-2 Lambda Variant May Give Vaccines a Harder Time
A group of researchers led by scientists at National Jewish Health, Denver, Colorado, and collaborators from China recently uploaded the results of their study to the preprint server bioRxiv. With a focus on the Lambda variant of interest, the study team recognized...
Rockefeller University Scientists Discuss ‘Superhuman’ Immunity to COVID-19
A group of researchers affiliated with the Rockefeller University in New York recently uploaded a study to the preprint server bioRxiv, meaning the works aren’t peer-reviewed as yet. Their study indicates that some people can have “superhuman immunity,” individuals...
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections
By Sivan Gazit, et al. Abstract Background Reports of waning vaccine-induced immunity against COVID-19 have begun to surface. With that, the comparable long-term protection conferred by previous infection with SARS-CoV-2 remains unclear. Methods We conducted...
Brain imaging before and after COVID-19 in UK Biobank
June 15, 2021 ~ MedRxiv ~ Gwenaëlle Douaud et al. Brain imaging before and after COVID-19 in UK Biobank Abstract There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain...
Necessity of COVID-19 vaccination in previously infected individuals
June 5, 2021 ~ MedRxiv ~ by Nabin K. Shrestha et al. Necessity of COVID-19 vaccination in previously infected individuals ABSTRACT Background The purpose of this study was to evaluate the necessity of COVID-19 vaccination in persons previously infected with...
Toxoplasmosis: An important risk factor for acquiring SARS-CoV-2 infection and a severe course of Covid-19 disease
By Jaroslav Flegr Summary Background Latent toxoplasmosis, i.e. a lifelong infection with the protozoan parasite Toxoplasma gondii, affects about a third of human population worldwide. In the past ten years, numerous studies had shown that infected...
Symptoms of Anxiety or Depressive Disorder and Use of Mental Health Care Among Adults During the COVID-19 Pandemic — United States, August 2020–February 2021
https://www.covidstrategies.org/symptoms-of-anxiety-or-depressive-disorder-and-use-of-mental-health-care-among-adults-during-the-covid-19-pandemic-united-states-august-2020-february-2021/https://www.cdc.gov/mmwr/volumes/70/wr/mm7013e2.htm?s_cid=mm7013e2_w Originally published by: CDC Author: Anjel Vahratian, et al. Date: 4/2/2021 Categories: Integrative Therapies,Recovery,Long Haul
Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response
By Long Chi Nguyen, et al. PREPRINT Abstract The rapid spread of COVID-19 underscores the need for new treatments. Here we report that cannabidiol (CBD), a compound produced by the cannabis plant, inhibits SARS-CoV-2 infection. CBD and its metabolite, 7-OH-CBD, but...
Outcomes of Ivermectin in the treatment of COVID-19: a systematic review and meta-analysis
https://www.covidstrategies.org/outcomes-of-ivermectin-in-the-treatment-of-covid-19-a-systematic-review-and-meta-analysis/https://www.medrxiv.org/content/10.1101/2021.01.26.21250420v1 Originally published by: MedRxiv Author: Castaneda-Sabogal et al. Date: 1/26/2021 Categories: Integrative Therapies,Treatment,Ivermectin
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19.
https://www.covidstrategies.org/review-of-the-emerging-evidence-demonstrating-the-efficacy-of-ivermectin-in-the-prophylaxis-and-treatment-of-covid-19/https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-Integrative Therapies,Treatment-of-COVID-19.pdf Originally published by: FLCCC Author: Pierre Kory, MD, et al. Date: 12/18/2020 Categories: Prevention,Integrative...
THE THERAPEUTIC POTENTIAL OF IVERMECTIN FOR COVID-19: A SYSTEMATIC REVIEW OF MECHANISMS AND EVIDENCE
https://www.covidstrategies.org/the-therapeutic-potential-of-ivermectin-for-covid-19-a-systematic-review-of-mechanisms-and-evidence/https://www.medrxiv.org/content/10.1101/2020.11.30.20236570v1.full Originally published by: MedRxIV Author: Kalfas, et al. Date: 12/4/2020 Categories: Integrative Therapies,Treatment,Ivermectin